Open AccessHepatocellular carcinoma tumor thrombus entering the inferior vena cava treated with percutaneous RF ablation: a case report
Author(s) -
Pietro Gatti,
Antonio Giorgio,
Emanuela Ciracì,
I. Roberto,
Alessandro Anglani,
Sergio Spano,
Fernando Rizzello,
Valentina Giorgio,
S Semeraro
Publication year - 2019
Publication title -
journal of ultrasound
Language(s) - English
Resource type - Journals
eISSN - 1971-3495
pISSN - 1876-7931
DOI - 10.1007/s40477-019-00361-w
Subject(s) - medicine , sorafenib , hepatocellular carcinoma , inferior vena cava , radiofrequency ablation , percutaneous , radiology , ablation , thrombus , regorafenib , surgery , cancer , colorectal cancer
Hepatocellular carcinoma (HCC) is the most common form of liver cancer. In advanced cancer stages (metastatic disease and/or vascular invasion), the generally accepted standard of care is systemic therapy using sorafenib as first-line treatment and, recently, regorafenib and nivolumab as second-line treatment, but the quality of life and the prognosis of patients remain very poor. Our paper reports a case of US-guided radiofrequency ablation (RFA) of both intraparenchymal HCC and inferior vena cava tumor thrombus.